021315 female pharm Flashcards

(35 cards)

1
Q

physiological effects of estrogen

A
  • enhances skeletal maturation and epiphyseal growth plate closure
  • feedback regulation of gonadotropin release
  • positive effects on bone mass
  • increases clotting
  • changes bile composition (increases saturation of bile with cholesterol-can cause gallstones)
  • increases amt of cervical mucus and water content (facilitates sperm penetration of cervix)
  • promotes endometrial proliferation
  • increases tubal contractility and favors uterine myometrium contractions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

progesterone and estrogen bioavailability

A

low oral bioavailability

half life of minutes due to first pass effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

physiologic effects of progesterone

A
  • decreases frequency of GnRH pulses (suppresses gonadotropin release)
  • decreases estrogen-driven endothemetrial proliferation and leads to development of secretory endomerium
  • changes cervical mucous to scant viscid material (sperm has difficulty penetrating)
  • maintenance of pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

main determinant for onset of menstruation

A

abrupt decline in progesterone at end of cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

mestranol is converted by the body to

A

ethinyl estradiol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ethinyl estradiol

A
synthetic estrogen
orally bioavailable (limits first pass effect)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

uses of estrogen

A

combination oral contraceptives (ethinyl estradiol or mestranol)

postmenopausal hormone replacement (equine estrogens, estradiol)

failure of pituitary fxn and ovarian development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adverse and toxic effects of estrogen

A
gallbladder disease
oral estrogens increase risk of thromboembolic dis
nausea and vomiting-initial use
breast swelling
migraine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

contraindications to estrogen use

A

pregnancy
estrogen-dependent cancers
undiagnosed uterine bleeding
thromboembolic disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

clomiphene

A

racemic mixture of two isomers (weak estrogen agonist and potent antagonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

use of clomiphene

A

induce ovulation (infertility due to anovulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA of clomiphene

A

inhibits action of stronger estrogens–inhibiting feedback on pituitary and hypothalamus. increases pulsatile gonadotropin release amplitude

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

side effects of clomiphene, tamoxifen, raloxifene, aromatase inhibitors

A

hot flashes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SERMs MOA

A

mixed estrogenic and antiestrogenic effects (tissue specific)

it’s anti-estrogenic in breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

use of tamoxifen

A

tx and prevention of breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

raloxifene MOA

A

estrogen agonist in bone

17
Q

use of raloxifene

A

prophylaxis of osteoporosis

breast cancer

18
Q

aromatase inhibitors

A

letrozole
anastrozole
exemestane

19
Q

suicide inhibitor that irreversibly inactivates aromatase

20
Q

uses of aromatase inhibitors

A

breast cancer

21
Q

medroxyprogesteron

A

progesterone analog

22
Q

norethindrone

A

19 nortestosterone derivative
primarily progestational rather than androgenic activity

ethinyl subsituent at C17 slows hepatic metabolism

23
Q

norgestrel

A

racemic mixture of inactive isomer and active isomer Levonorgestrel

13 ethyl substituent results in more potent progestin with less androgenic activity than norethindrone

24
Q

drospirenone

A

spironolactone analogue

has ANTI-MINERALCORTICOID and progestin activity

25
use of drospirenone
pregnancy prevention emotional and physical symptoms of premenstural dysphoric disorder (to reduce tendency toward edema) moderate acne vulgaris
26
uses of progestins
hormonal contraceptives post menopausal hormone replacement therapy (with an estrogen b/c want to limit the proliferation that would occur with estrogen alone) others-secondary amenorrhea, endometrial hyperplasia
27
adverse effects of progestins
headache breakthrough bleeding androgenic actions-acne, hirsutism
28
mifepristone
competitive progesterone receptor modulator. mainly an antagonist
29
use of mifepristone
pregnancy termination
30
MOA of mifepristone
causes decidual breakdown | sensitizes myometrium to contractile actions of PGs
31
how is mifepristone administered
in combo with PG (misoprostol) to ensure expulsion of blastocyst
32
ulipristal
selective progesterone receptor modulator partial agonist
33
use of ulipristal
emergency contraception
34
MOA of ulipristal
inhibits ovulation by inhibiting LH release which inhibits LH-induced follicular rupture in ovary
35
emergency contraception
combined oral contraceptives (levonorgestrel and ethinyl estradiol) levonorgestrel alone ulipristal